adhdguideline.aadpa.com.auAustralian Evidence-Based Clinical Practice ADHD

Guideline Hit enter to search or ESC to closesearch Menu Download The Guideline Recommendations Summary Download Summary of recommendations Ch 1-3 Identification High-risk groups, screening and identification Diagnosis Co-occurring conditions, differential diagnosis and information needs Treatment & Support Multimodal treatment and support, and transitions Ch 4-5 Non-pharmacological interventions Lifestyle changes, cognitive training, ADHD coaching and other interventions Pharmacological interventions Medication choice, monitoring treatments and adherence Considerations – Subgroups Aboriginal & Torres Strait Islander peoples, people in the correctional system and co-occurring substance use discorders Ch 6-8 Considerations – Service & Policy Service and configuration, and professional training Considerations – Research Non-pharmacological and pharmacological treatments, subgroups, models of care and emerging approaches About The Guideline About Foreword Abstract Executive Summary Introduction Methods Principles and assumptions Col 2 Background Technical Report Guideline development group Public consultation Administrative information Contact Us Factsheets Order Guideline Visit AADPA search First Edition Australian Evidence-Based Clinical Practice Guideline For Attention Deficit Hyperactivity Disorder (ADHD) This clinical practice guideline is for the identification, diagnosis, and treatment of people with ADHD. It outlines a roadmap for ADHD clinical practice, research and policy, now and in the future, with a focus on everyday functioning and quality of life for people who are living with ADHD and those who support them. Download the Guideline Get The Summary Of Recommendations Download the ADHD Guideline Consumer Companion The complex language and technical nature of the Australian Evidence-Based Clinical Practice Guideline for ADHD may present challenges for those without a clinical background to understand fully. To address this, a Consumer Companion was developed to make the information in the Guideline more accessible for individuals with ADHD, their families, and other stakeholders. Get the Consumer Companion Guideline Factsheets Download free factsheets for clinicians and individuals with lived experience of ADHD Filter Factsheets Educational Adjustments For Students With ADHD Students with ADHD can benefit from educational adjustments to ensure their needs are met… Read More ADHD Factsheet For Educators It is important for educators to be aware of ADHD, including how to recognise potential… Read More ADHD Diagnosis Checklist This ADHD diagnosis checklist is designed to aid in the diagnostic process to ensure… Read More ADHD Myths & Misinformation There are many myths about ADHD in the community which can create stigma and… Read More ADHD Factsheet for GPs More than 1 million Australians have ADHD. If left untreated, ADHD can result in… Read More ADHD and co-occurring substance use disorder People with ADHD are 50% more likely to develop a drug or alcohol use… Read More ADHD in the correctional system The prevalence of ADHD is much higher in people in the correctional system than… Read More ADHD & Aboriginal & Torres Strait Islander Peoples Download this free factsheet on the identification, diagnosis and treatment of ADHD in Aboriginal… Read More View All Factsheets Approvals This guideline has been approved by the NHMRC and endorsed by APS, RACP, RACGP, Speech Pathology Australia, Occupational Therapy Australia, ACPA, AAPI, ADHD WA, ADHD Foundation, RANZCP, ADHD Australia and the World Federation of ADHD. © Australasian ADHD Professionals Association. Privacy Policy | Website TermsDownload The Guideline Recommendations Summary Download Summary of recommendations Ch 1-3 Identification High-risk groups, screening and identification Diagnosis Co-occurring conditions, differential diagnosis and information needs Treatment & Support Multimodal treatment and support, and transitions Ch 4-5 Non-pharmacological interventions Lifestyle changes, cognitive training, ADHD coaching and other interventions Pharmacological interventions Medication choice, monitoring treatments and adherence Considerations – Subgroups Aboriginal & Torres Strait Islander peoples, people in the correctional system and co-occurring substance use discorders Ch 6-8 Considerations – Service & Policy Service and configuration, and professional training Considerations – Research Non-pharmacological and pharmacological treatments, subgroups, models of care and emerging approaches About The Guideline About Foreword Abstract Executive Summary Introduction Methods Principles and assumptions Col 2 Background Technical Report Guideline development group Public consultation Administrative information Contact Us Factsheets Order Guideline...